期刊
NATURE IMMUNOLOGY
卷 12, 期 8, 页码 786-U149出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ni.2067
关键词
-
类别
资金
- US National Institutes of Health [U19AI090023, HHSN266200700006C, U54AI057157, R37AI48638, R01DK057665, U19AI057266, N01 AI50025, AI30048, AI057266, DK074701, UL1 RR025008]
- Bill & Melinda Gates Foundation [38645]
- National Science Foundation (E.K.L. laboratory)
- Centers for Disease Control (E.K.L. laboratory)
- Directorate For Engineering
- Div Of Civil, Mechanical, & Manufact Inn [800057] Funding Source: National Science Foundation
Here we have used a systems biology approach to study innate and adaptive responses to vaccination against influenza in humans during three consecutive influenza seasons. We studied healthy adults vaccinated with trivalent inactivated influenza vaccine (TIV) or live attenuated influenza vaccine (LAIV). TIV induced higher antibody titers and more plasmablasts than LAIV did. In subjects vaccinated with TIV, early molecular signatures correlated with and could be used to accurately predict later antibody titers in two independent trials. Notably, expression of the kinase CaMKIV at day 3 was inversely correlated with later antibody titers. Vaccination of CaMKIV-deficient mice with TIV induced enhanced antigen-specific antibody titers, which demonstrated an unappreciated role for CaMKIV in the regulation of antibody responses. Thus, systems approaches can be used to predict immunogenicity and provide new mechanistic insights about vaccines.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据